Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
Masi, Gianluca, Dr, Loupakis, Fotios, MD, Salvatore, Lisa, MD, Fornaro, Lorenzo, MD, Cremolini, Chiara, MD, Cupini, Samanta, MD, Ciarlo, Andrea, MD, Del Monte, Francesca, PhD, Cortesi, Enrico, MD, Amoroso, Domenico, MD, Granetto, Cristina, MD, Fontanini, Gabriella, Prof, Sensi, Elisa, MD, Lupi, Cristiana, MD, Andreuccetti, Michele, CTA, Falcone, Alfredo, MD
Published in The lancet oncology (01.09.2010)
Published in The lancet oncology (01.09.2010)
Get full text
Journal Article